Femasys Inc. (FEMY) vs KALA BIO, Inc. (KALA)
A side-by-side comparison of Femasys Inc. and KALA BIO, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FEMY
Femasys Inc.
$2.06HealthcareDelayed quote: Oct 6, 2026, 1:28 PM EDT
KALA
KALA BIO, Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
Total return — FEMY vs KALA
growth of $100 · dividends reinvested · last 5yFEMY -99.2% (-61.5%/yr)KALA -100.0% (-88.0%/yr)FEMY compounded faster over this window
Log scale — wide-divergence pair
FEMY KALA
FEMY vs KALA: by the numbers
- •KALA is the larger company ($7M vs $6M market cap).
- •Both run net losses; KALA's is the smaller (0.00% vs -534.27% net margin).
Metrics side by side
Valuation
| Metric | FEMY | KALA |
|---|---|---|
| P/S ratio | 2.71 | N/A |
| P/B ratio | 1.54 | 0.78 |
Profitability
| Metric | FEMY | KALA |
|---|---|---|
| Gross margin | 61.96% | 0.00% |
| Operating margin | -763.90% | 0.00% |
| Net margin | -534.27% | 0.00% |
| ROE | -304.78% | -111.46% |
| ROIC | -209.05% | -232.05% |
Growth (annualized)
| Metric | FEMY | KALA |
|---|---|---|
| Revenue CAGR (5Y) | 12.97% | N/A |
| Total return CAGR (5Y) | -57.27% | -85.73% |
Frequently asked
- How have FEMY and KALA total returns compared?
- Over the past 5 years, FEMY delivered -57.27% and KALA delivered -85.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.